The K-M survival curve analysis also confirmed that ThyC patients with higher expression levels of GGCT exhibited significantly different prognostic outcomes compared to those who had relatively lower expressions of GGCT, in this cohort. The gene discussed is GGCT; the disease is thymic carcinoma.